Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria-Reference-Cited by-同舟云学术

Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria

Published:2015-05 Issue:2 Volume:33 Page:381-400
ISSN:0733-8619
Container-title:Neurologic Clinics
language:en
Short-container-title:Neurologic Clinics

Author:

Marchidann Adrian,Balucani Clotilde,Levine Steven R.

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference130 articles.

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke study group;N Engl J Med,1995

2. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years;Adeoye;Stroke,2011

3. Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke;Cronin;Stroke,2014

4. The exact science of stroke thrombolysis and the quiet art of patient selection;Balami;Brain,2013

5. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment;O'Connor;Ann Emerg Med,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Management of Ischemic Stroke in the Postanesthesia Care Unit;Journal of PeriAnesthesia Nursing;2019-10

2. Contraindications with recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke population;Neurology, Psychiatry and Brain Research;2018-02

3. Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?;Aging and disease;2018

4. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling;Indian Pacing and Electrophysiology Journal;2018-01

5. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke;Brain Injury;2016-08-02